-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULAR THERAPEUTIX SHARES UP 12.7% PREMARKET AFTER RIVAL EYEPOINT'S EYE DRUG MISSES MAIN GOAL IN LATE-STAGE TRIAL

路透·08/17/2026 12:52:12

登錄查看新聞詳情